Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: From phenotyping to genotyping

Current Opinion in Allergy and Clinical Immunology

Volumn 14, Issue 4, 2014, Pages 271-277

  Blanca López, Natalia ^a   Barrionuevo, Ester ^b   Andreu, Inmaculada ^c   Canto, María G ^a  

^a HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

Author keywords

clinical entities; genotypes; mechanisms; NSAIDs hypersensitivity; phenotypes

Indexed keywords

4 AMINOPHENOL; ACETYLSALICYLIC ACID; ANTHRANILIC ACID DERIVATIVE; ARYLACETIC ACID DERIVATIVE; ARYLPROPIONIC ACID DERIVATIVE; CELECOXIB; DICLOFENAC; IBUPROFEN; INDOLEACETIC ACID; INDOMETACIN; MEFENAMIC ACID; NABUMETONE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL DERIVATIVE; PIROXICAM; SALICYLIC ACID DERIVATIVE;

ALLERGIC REACTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ATOPY; DELAYED HYPERSENSITIVITY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG USE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN DISEASE; URTICARIA; CHEMICALLY INDUCED; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG HYPERSENSITIVITY; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; RESPIRATORY TRACT DISEASES; SKIN DISEASES;

EID: 84903762907     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000077     Document Type: Review

References (62)

1. Doña I, Blanca-Lopez N, Torres MJ, et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol 2012; 22:363-371.
2. Messaad D, Sahla H, Benahmed S, Godard Pet al. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004; 140:1001-1006.
3. Roberts LJ, Morrow JD. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LL, Goodman Gilman A, editors. The pharmacological basis of therapeutics, 10th edn New York: McGraw-Hill; 2001. pp. 687-731.
4. Kowalski ML, Makowska JS, Blanca M, et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA. Allergy 2011; 66:818-829.
5. Kowalski ML, Asero R, Bavbek S, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal antiinflammatory drugs. Allergy 2013; 68:1219-1232.
6. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the nomenclature review committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113:832-836.
7. Szczeklik A, Nizankowska E, Sanak M. Hyperesensiivity to aspirin and non steroidal anti-inflammatory drugs. In: Adkinson NF, Brochner BS, Busse WW, Holgate ST, Lemaske RF, Simons FER, editors. Allergy, principles and practice, 7th edition St Louis: Elsevier; 2009. pp. 1227-1246.
8. Canto MG, Andreu I, Fernandez J, Blanca M. Selective immediate hypersensitivity reactions to NSAIDs. Curr Opin Allergy Clin Immunol 2009; 9:293-297.
9. Doña I, Blanca-Lopez N, Cornejo-García JA, et al. Characteristics of subjects experiencing hypersensitivity to nonsteroidal anti-inflammatory drugs: patterns of response. Clin Exp Allergy 2011; 41:86-95.
10. Ayuso P, Blanca-Lopez N, Doña I, et al. Advanced phenotyping in hypersensitivity drug reactions to NSAIDs. Clin Exp Allergy 2013; 43:1097-1109.
11. Mastalerz L, Setkowicz M, Szczekik A. Mechanism of chronic urticaria exacerbation by aspirin. Curr Allerg Asth Rep 2005; 5:277-283.
12. Blanca-Lopez N, Torres MJ, Doña I, et al. Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance. Clin Exp Allergy 2013; 43:85-91.
13. Doña I, Blanca-López N, Torres MJ, et al. NSAID-induced urticaria/angioedema does not evolve into chronic urticaria: a 12-year follow-up study. Allergy 2014; 69:438-444.
14. Asero R. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J Allergy Clin Immunol 2003; 111:1095-1098.
15. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. NSAID-induced, urticaria and angioedema: a reappraisal of its clinical management. Am J Clin Dermatol 2002; 3:599-607.
16. Rafiq R. Isolated periorbital angio-oedema induced by aspirin: a case report and review of the literature. Dent Update 2007; 34:302-304.
17. Quiralte J, Blanco C, Castillo R, et al. Intolerance to Nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol 1996; 98:678-685.
18. Caimmi S, Caimmi D, Bousquet PJ, et al. How can we classify NSAID hypersensitivity reactions? Validation from a large database. Int Arch Allergy Immunol 2012; 159:306-312.
19. Torres MJ, Mayorga C, Blanca M. Nonimmediate allergic reactions induced by drugs: pathogenesis and diagnostic tests. J Investig Allergol Clin Immunol 2009; 19:80-90.
20. Gomez E, Blanca-Lopez N, Torres MJ, et al. Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin Exp Allergy 2009; 39:1217-1224.
21. Gamboa PM, Sanz ML, Caballero MR, et al. Use of CD63 expression as a marker of in vitro basophil activation and leukotriene determination in metamizol allergic patients. Allergy 2003; 58:312-317.
22. Carmona MJ, Blanca M, Garcia A, et al. Intolerance to piroxicam in patients with adverse reactions to nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 1992; 90:873-879.
23. Kang LW, Kidon MI, ChinCW, et al. Severe anaphylactic reaction to ibuprofen in a child with recurrent urticaria. Pediatrics 2007; 120:e742-e744.
24. Takahama H, Kubota Y, Mizoguchi M. A case of anaphylaxis due to ibuprofen. J Dermatol 2000; 27:337-340.
25. Park BK, Naisbitt DJ, Gordon SF, et al. Metabolic activation in drug allergies. Toxicology 2001; 158:11-23.
26. Brooks CJ, Gilbert MT. Studies of urinary metabolites of 2-(4-isobutylphenyl) propionic acid by gas-liquid chromatography-mass spectrometry. J Chromatogr 1974; 99:541-551.
27. Atarashi K, Kabashima K, Akiyama K, et al. Stimulation of Langerhans cells with ketoprofen plus UVA in murine photocontact dermatitis to ketoprofen. J Dermatol Sci 2007; 47:151-159.
28. Harrer A, Lang R, Grims L, et al. Diclofenac hypersensitivity: antibody responses to the parent drug and relevant metabolites. Plos One 2010; 5:e13707.
29. Jonker MJ, Bruynzeel DP. Anaphylactic reaction elicited by patch testing with diclofenac. Contact Dermatitis 2003; 49:114-115.
30. Mayorga C, Torres MJ, Fernandez J, et al. Cutaneous symptoms in, drug allergy: what have we learnt? Curr Opin Allergy Clin Immunol 2009; 9:431-436.
31. Mayorga C, Pena RR, Blanca-López N, et al. Monitoring the acute phase response in nonimmediate allergic drug reactions. Curr Opin Allergy Clin Immunol 2006; 6:249-257.
32. Alvarez Santullano CV, Tover Flores V, De Barrio Fernandez M, et al. Fixed drug eruption due to ibuprofen. Allergol Immunopathol 2006; 34:280-281.
33. Ozdemir SK, Erkekol FO, Aydin O, et al. Fixed drug eruption due to meloxicam. J Investig Allergol Clin Immunol 2011; 21:419-420.
34. Andrade P, Brinca A, Gonzalo M. Patch testing in fixed drug eruptions-a, 20-year review. Contact Dermatitis 2011; 65:195-201.
35. Lamchahab F, Baeck M. Occupationally induced fixed drug eruption caused by a nonsteroidal anti-inflammatory agent. Contact Dermatitis 2012; 67:176-177.
36. Hanafusa T, Azukizawa H, Matsumura S, et al. Nonpigmenting fixed drug eruption caused by an over-the-counter nonsteroidal anti-inflammatory drug: drug-specific CD8+ T lymphocytes identified in peripheral blood. Eur J Dermatol 2012; 22:680-682.
37. Albes B, Marguery MC, Schwarze HP, et al. Prolonged photosensitivity following contact photoallergy to ketoprofen. Dermatology 2000; 201:171-174.
38. Drug-induced photosensitivity. Prescrire Int 2009; 103:208-211.
39. Andreu I, Mayorga C, Miranda MA. Generation of reactive intermediates in photoallergic reactions. Curr Opin Allergy Clin Immunol 2010; 10:303-308.
40. Gebhardt M, Wollina U. Cutaneous side-effects of nonsteroidal anti-inflammatory drugs (NSAID). Z Rheumatol 1995; 54:405-412.
41. Fernández-Jorge B, Goday-Buján JJ, Murga M, et al. Photoallergic contact dermatitis due to diclofenac with cross-reaction to aceclofenac: two case reports. Contact Dermatitis 2009; 61:236-247.
42. Trujillo MJ, de Barrio M, Rodríguez A, et al. Piroxicam-induced photodermatitis. Cross-reactivity among oxicams: a cross-report. Allergol Immunopathol 2001; 29:133-136.
43. Naisbitt DJ, Sanderson LS, Meng X, et al. Investigation of the immunogenicity of diclofenac and diclofenac metabolites. Toxicol Lett 2007; 168:45-50.
44. Roujeau JC. Clinical aspects of skin reactions to NSAIDs. Scand J Rheumatol Suppl 1987; 65:131-134.
45. Szszeklik A, Morrow JD, Nizankowska E, Sanak M. Hypersensitivity to aspirin and non-steroidal antiinflmmatory drugs. In: Adkinson NF, Brochner BS, Busse WW, editors. Allergy, principles and practice, 7th edn Philadelphia: Elsevier; 2007. pp. 1227-1246.
46. Bigby M, Stern R. Cutaneous reactions to nonsteroidal anti-inflammatory drugs. A review. J Am Acad Dermatol 1985; 12:866-876.
47. Asero R. Multiple non steroidal anti-inflammatory drug induced cutaneous disease: what differentiates patients with and without underlyng chornic spontaneous urticaria. Int Arch Allergy Immunol 2014; 163:114-118.
48. Morisset M, Moneret-Vautrin DA. Food anaphylaxis induced by aspirin. Allerg Immunol 2001; 33:147-149.
49. Harada S, Horikawa T, Ashida M, et al. Aspirin enhances the induction of type I allergic symptoms when combined with food and exercise in patients with fooddependent exercise-induced anaphylaxis. Br J Dermatol 2001; 145:336-339.
50. Nakamura K, Inomata N, Ikezawa Z. Dramatic augmentation of wheat allergy by aspirin in a dose-dependent manner. Ann Allergy Asthma Immunol 2006; 97:712-713.
51. Aihara M, Miyazawa M, Osuna H, Tsubaki K, et al. Food-dependent exerciseinduced anaphylaxis: influence of concurrent aspirin administration on skin testing and provocation. Br J Dermatol 2002; 146:466-472.
52. Duroudier NP, Tulah AS, Sayers I. Leukotriene pathway genetics and pharmacogenetics in allergy. Allergy 2009; 64:823-839.
53. Kim SH, Ye YM, Palikhe NS, et al. Genetic and ethnic risk factors associated with drug hypersensitivity. Curr Opin Allergy Clin Immunol 2010; 10:280-290.
54. Kim SH, Sanak M, Park HS. Genetics of hypersensitivity to aspirin and nonsteroidal anti-inflammatory drugs. Immunol Allergy Clin North Am 2013; 33:177-194.
55. Park SM, Park JS, Park HS, Park CS. Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways. Allergy Asthma Immunol Res 2013; 5:258-276.
56. Cornejo-García JA, Jagemann LR, Blanca-López N, et al. Genetic variants of the arachidonic acid pathway in nonsteroidal anti-inflammatory drug-induced acute urticaria. Clin Exp Allergy 2012; 42:1772-1781.
57. Park BL, Kim T-H, Kim J-H, et al. Genome-wide association study of aspirinexacerbated respiratory disease in a Korean population. Hum Genet 2013; 132:313-321.
58. Kim J-H, Park B-L, Cheong HS, et al. Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma. PloS One 2010; 5:e13818.
59. Cornejo-García JA, Liou L-B, Blanca-López N, et al. Genome-wide association study in NSAID-induced acute urticaria/angioedema in Spanish and Han Chinese populations. Pharmacogenomics 2013; 14:1857-1869.
60. Shin S, Park JS, Kim Y-J, et al. Differential gene expression profile in PBMCs from subjects with AERD and ATA: a gene marker for AERD. Mol Genet Genomics MGG 2012; 287:361-371.
61. Cheong HS, Park S-M, Kim M-O, et al. Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics. Allergy 2011; 66:637-644.
62. Perkins JR, Ayuso P, Cornejo-García JA, Ranea JA. The study of severe cutaneous drug hypersensitivity reactions from a systems biology perspective. Curr Opin Allergy Clin Immunol 2014; 14:301-306.